The Future of Precision Oncology in Nuclear Medicine

The Future of Precision Oncology in Nuclear Medicine



Theranositics image

The National  Steering Committee invites you to join the first National Theranostics Round Table:

The Future of Precision Oncology in Nuclear Medicine

When:
Thursday October 28

Where:
This is a virtual event, please register to join.

Agenda

9.00am – 9.15am

Welcome

Simone Leyden (NECA)

Paul Cross (Moderator)

Hon Greg Hunt MP (Minister for Health and Aged Care – TBC)

9.15am – 10.00am

What is Theranostics? The Australian experience – Imaging and therapy past, present and future

Prof Rod Hicks (Peter MacCallum Cancer Centre)

Prof Louise Emmett (St Vincents Hospital)

10.00am–10.45am

Clinical trials and innovative technologies

A/Prof Grace Kong (Peter MacCallum Cancer Centre)

Prof Nick Pavlakis (Royal North Shore)

A/Prof Ros Francis (ARTNET)

Prof Kristofer Thurecht (University of Queensland)

10.45-10.55am

NET patient experience

Lynda Dunstone

10.55am-11.10am

Morning tea

 

11.10am-11.45am

Innovative models of care: rare and less common v common cancers

Prof Michael Michael (Peter MacCallum Cancer Centre)

Prof Andrew Scott (Austin Hospital)

Dr Aviral Singh (GenesisCare)

11.45am-12.30pm

Importance of investment now for the future  

“Think Global – Act Local”

Dr   Dr David Cade (Telix)

Dr Keith Hansen (GenesisCare)

Dr Simon Puttick (AdvanCell Isotopes)

Greg Santamaria (Cyclotek) 

Dr Alan Taylor (Clarity Pharmaceuticals)

Daniel Bucki-Smith (Global Medical Solutions)

12.30pm-1.15pm

Sovereign capability, future workforce & infrastructure

Shaun Jenkinson (ANSTO)

Prof Dale Bailey (Royal North Shore)

Dr Geoff Schembri (Australasian Association of Nuclear Medicine Specialists)

1.15pm – 1.25pm

Prostate cancer patient experience

Dr Paul Davis

1.25pm-1.45pm

Lunch

 

1.45pm-2.30pm

Trade opportunities, industry performers and supply chains

Amanda Rotger MD (ITM Germany)

Rosanne Robinson (ANSTO)

Matthew Ashton (Global Medical Solutions)

Christopher Sturla (Business Manager Molecular Imaging ANZ, Siemens Healthineers)

Amit Yadav (GE Healthcare)

2.30pm-3.15pm

Time for a rethink –  HTA Framework for the future

Adjunct Prof John Skerritt (Department of Health)

Dr Megan Keaney (Department of Health)

Prof Robyn Ward (MSAC)

Prof Dorothy Keefe (CEO – Cancer Australia)

3.15pm-4.00pm

Solutions – Moderated Panel discussion

Prof Dorothy Keefe (CEO – Cancer Australia)

Dr Mike Freelander MP (Member for Macarthur, NSW)

Dr Katie Allen MP (Member for Higgins, VIC)

Simone Leyden (CEO – NECA)

Dr Jane Fisher (Movember)

Elizabeth de Somer (Medicines Australia)

4:00pm

Close event

Hon Mark Butler MP, Shadow Minister for Health and Aging

With thanks to:

Theranostics Logos 13 1

National Steering Committee

simone-headshot

Simone Leyden

Neuroendocrine Cancer Australia

Rod Hicks Cropped Web 1

Prof Rod Hicks

Peter MacCallum Cancer Centre

Michael Michael

Prof Michael Michael

Peter MacCallum Cancer Centre

Dale Bailey Cropped

Prof Dale Bailey

Royal North Shore Hospital

Nick Pavlakis Image

Prof Nick Pavlakis

Royal North Shore Hospital

Louise Emmett Image

Prof Louise Emmett

St Vincent’s Hospital (Sydney)

Daniel Badger

Dr Daniel Badger

ANZSNM

Nat Lanzo

Prof Nat Lenzo

GenesisCare

Rosanne RobinsonCropped

Rosanne Robinson

ANSTO

Share this event

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related Events

Will Norman Nurse Webinar on Neuroendocrine Cancer 2026

Date: March 20, 2026
Start Time: 7:00 am

Living with NETs – March 2026

Date: March 3, 2026
Start Time: 1:30 pm

Equitable Access to Cancer Care: Reflection on the Senate Inquiry Parliamentary Event

Date: October 30, 2025
Start Time: 3:30 pm

Sydney NET Patient Forum

Date: October 28, 2025
Start Time: 5:30 pm

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.